Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,438.22
(
0.31%
)
News Focus
News Focus
Post# of 824113
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Rkmatters

Send PM Follow Ignore
Followers 120
Posts 6384
Boards Moderated 0
Alias Born 08/17/2014

Rkmatters

Re: Evaluate post# 53752

Saturday, 02/13/2016 11:33:55 PM

Saturday, February 13, 2016 11:33:55 PM

Post# of 824113
That wouldn't be a mono-therapy if there was one. That would change things. Odds for success would improve dramatically in their favor, in my opinion, if they could combine with an agent that combats immunosuppression.

But nope, no checkpoint inhibitor as of yet. Only mentioned a discussion a year ago. Nothing has become of it. They certainly want to partner.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News